Literature DB >> 33403883

Accuracy of Finnish Cancer Registry colorectal cancer data: a comparison between registry data and clinical records.

Pipsa Lunkka1,2, Nea Malila2, Heidi Ryynänen2, Sanna Heikkinen2, Ville Sallinen1,3, Laura Koskenvuo1.   

Abstract

BACKGROUND: The population-based Finnish Cancer Registry (FCR) is an important resource for research and healthcare politics in Finland. The aim of this study was to validate the accuracy of the colorectal cancer (CRC) data within the FCR.
MATERIAL AND METHODS: FCR data are based on independent cancer report forms (CRFs) from both clinicians and pathologists. Data from patients diagnosed with CRC during a randomized, population-based CRC screening program between 2004 and 2012 were extracted from the FCR and compared to data extracted from the original clinical patient records of these individuals by two gastrointestinal surgeons. The study focused on tumour characteristics and primary treatment. Accuracy was measured by calculating Cohen's kappa coefficient (κ), which considers the possibility of agreement by chance.
RESULTS: Altogether, 1475 patients were studied. κ was 0.74 for stage, 0.87 for tumour location (right/left), 0.78 for a more detailed location, 0.72 for tumour histology, 0.46 for surgical removal of the primary tumour, and 0.43 for chemotherapy. Among those who underwent surgery, the radicality of surgical treatment had a κ of 0.24. In total, 173 (12%) patients were lacking a CRF from a clinician.
CONCLUSION: The FCR data had good accuracy regarding tumour characteristics, but poor accuracy in treatment information. The main reason for this suboptimal accuracy was missing CRFs from treating clinicians. Awareness of these findings is crucial when research and decision making is based on FCR data. Measures have since been taken to improve the completeness of FCR recording.

Entities:  

Keywords:  Finland; Registries; colorectal cancer; colorectal neoplasms; data accuracy

Mesh:

Year:  2021        PMID: 33403883     DOI: 10.1080/00365521.2020.1867893

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  4 in total

1.  Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up.

Authors:  John C Mathers; Faye Elliott; Finlay Macrae; Jukka-Pekka Mecklin; Gabriela Möslein; Fiona E McRonald; Lucio Bertario; D Gareth Evans; Anne-Marie Gerdes; Judy W C Ho; Annika Lindblom; Patrick J Morrison; Jem Rashbass; Raj S Ramesar; Toni T Seppälä; Huw J W Thomas; Harsh J Sheth; Kirsi Pylvänäinen; Lynn Reed; Gillian M Borthwick; D Timothy Bishop; John Burn
Journal:  Cancer Prev Res (Phila)       Date:  2022-09-01

2.  Long-term survival among colorectal cancer patients in Finland, 1991-2015: a nationwide population-based registry study.

Authors:  Tobias Olenius; Laura Koskenvuo; Selja Koskensalo; Anna Lepistö; Camilla Böckelman
Journal:  BMC Cancer       Date:  2022-04-02       Impact factor: 4.430

3.  Gastric cancer completeness in Finnish Cancer Registry and Finnish Patient Registry: a population-based nationwide retrospective cohort study.

Authors:  Urgena Maharjan; Joonas H Kauppila
Journal:  BMJ Open       Date:  2022-04-19       Impact factor: 3.006

4.  Shared environment and colorectal cancer: A Nordic pedigree registry-based cohort study.

Authors:  Rahma Elmahdi; Elna C M Wennerström; Mikael Andersson; Jan Wohlfahrt; Mads Melbye; Eero Pukkala; Maria Hortlund; Kaisa Silander; Kyösti Sutinen; Tine Jess; Joakim Dillner
Journal:  Int J Cancer       Date:  2022-06-22       Impact factor: 7.316

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.